Flexible Endoscopes Market - By Product, By Application, By End Use - Global Forecast, 2025 - 2034

Flexible Endoscopes Market Size

The global flexible endoscopes market was estimated at USD 8.1 billion in 2024. The market is expected to grow from USD 8.6 billion in 2025 to USD 16.2 billion in 2034, growing at a CAGR of 7.3%. This high growth is attributed to several factors, including the growing prevalence of chronic conditions, increasing popularity of minimally invasive therapies, and rising health awareness and demand for early-stage diagnosis. Advancements in visualization, precision, and patient comfort are further fueling market expansion positively.
 

Flexible endoscopes are medical devices with a flexible insertion tube, enabling doctors to pass intricate anatomical paths for diagnosis and treatment with minimal invasiveness. The key players in the market are BD, Boston Scientific, CooperSurgical, OLYMPUS, and PENTAX Medical.
 

The market grew from USD 6.9 billion in 2021 to USD 7.6 billion in 2023. This growth was primarily driven by several transformative trends. One of the key drivers of growth has been the growing incorporation of minimally invasive procedures, which have lower recovery times and reduced healthcare expenses. Additionally, increased demand for outpatient settings and ambulatory surgical centers has contributed to heightened demand further, as flexible endoscopes support cost-effective and patient-centered diagnostics and interventions for a broad range of specialties.
 

The market for flexible endoscopes is growing strongly, driven by increasing rates of chronic diseases like gastrointestinal illness, respiratory illness, and cancer. For instance, OECD data in 2021 recorded that, on average across 24 OECD countries, over a third of adults lived with a long-standing illness or health issue. Such chronic diseases usually need long-term monitoring and minimally invasive diagnostic tests, which flexible endoscopes are perfectly positioned to service.
 

Additionally, the increased popularity of minimally invasive therapies is further driving the growth of the flexible endoscopes market. These procedures have a number of benefits, such as minimized patient trauma, shorter hospital stays, quicker recovery periods, and reduced total healthcare costs. For instance, as per the National Library of Medicine, in 2022, in the U.S., more than 17.7 million gastrointestinal endoscopic procedures were carried out annually, which accounted for approximately 68% of all endoscopic procedures. Flexible endoscopes are critical in improving the outcomes of patients, making complicated procedures easy, and in making it possible for health care professionals to provide more efficient care.
 

Flexible endoscopes refer to the endoscopy devices that are intended to be inserted into the body during minimally invasive endoscopic procedures for examination, diagnosis, or therapeutic purposes.
 

Flexible Endoscopes Market Trends

The rapid pace of technological advancements is a major driver of growth in the flexible endoscope market, enabling significant improvements in diagnostic accuracy, therapeutic precision, and patient outcomes.

 

• One of the most impactful technological developments in flexible endoscopes is the integration of high-definition (HD) and 4K imaging systems. For instance, Olympus Corporation offers the EVIS EXERA III system, which provides superior imaging quality through its high-definition video endoscopes. With improved resolution and clarity, physicians can obtain better visualization of intricate anatomical structures, enhancing diagnostic accuracy and therapeutic precision.
   
• Additionally, innovations such as robotic-assisted endoscopy are transforming minimally invasive procedures. For instance, Medtronic’s Hugo Robotic-Assisted Surgical System allows surgeons to perform endoscopic procedures with enhanced precision and control. This system supports various minimally invasive surgeries and expands the potential for therapeutic interventions, limiting patient recovery times.
   
• Moreover, recent advancements in materials science have led to the development of smaller and more flexible endoscopes. Innovations in design and manufacturing allow for easier navigation through the complex anatomy of the gastrointestinal tract and other regions. This miniaturization enables access to previously unreachable areas, broadening the diagnostic and therapeutic capabilities of endoscopic procedures
   
• Furthermore, technologies like narrow-band imaging (NBI) and fluorescence imaging improve the detection of subtle vascular and mucosal patterns, further elevating diagnostic capabilities.
   

Flexible Endoscopes Market Analysis

The global market was valued at USD 6.9 billion in 2021. The market size reached USD 7.6 billion in 2023, from USD 7.2 billion in 2022.
 

Based on the product, the market is segmented into videoendoscope and fiberscope. The videoendoscope segment accounted for 64.6% of the market in 2024 due to its high diagnostic utility, technological innovation, and ability to support complex surgical procedures. The segment is expected to exceed USD 10.8 billion by 2034, growing at a CAGR of 7.6% during the forecast period. On the other hand, the fiberscope segment is expected to grow with a CAGR of 6.7%. The growth of this segment can be attributed to their flexibility, compact size, and cost-effectiveness.
 

• The dominance of videoendoscope segment is largely attributed to the superior imaging quality offered by video endoscopes, which enables high-definition visualization of internal organs and tissues.
   
• These devices are equipped with miniature cameras and advanced optics that transmit real-time images to external monitors, allowing for more accurate diagnostics and minimally invasive procedures.
   
• Their utility spans across various medical specialties, including gastroenterology, pulmonology, urology, and gynecology, making them indispensable tools in modern clinical practice.
   
• Moreover, the integration of AI-powered image analysis, 3D imaging, and wireless connectivity has further enhanced the functionality and appeal of video endoscopes. These innovations not only improve diagnostic precision but also streamline workflow efficiency in hospitals and clinics. As a result, healthcare providers are increasingly shifting from traditional fiberoptic endoscopes to video-based systems.
   

Based on the application, the flexible endoscopes market is segmented into GI endoscopy, pulmonary endoscopy, ENT endoscopy, urology, and other applications. The GI endoscopy segment accounted for the highest market share of 40.6% in 2024 due to rising disease prevalence, heightened awareness of health screenings, and ongoing technological innovations.
 

• The increasing prevalence of gastrointestinal diseases such as ulcers, tumors, and inflammatory bowel diseases is a major factor propelling the market dominance for the GI endoscopy segment. For instance, according to an article published by JMIR Infodemiology, in 2021, more than 6 million people were affected by inflammatory bowel disease (IBD) globally.
   
• Additionally, the trend toward minimally invasive procedures has contributed to the dominance of GI endoscopy in the flexible endoscope market. Compared to traditional surgical approaches, GI endoscopy offers reduced recovery times, minimal patient discomfort, and lower complication rates, making it a preferred choice among patients and healthcare providers alike.
   
• Moreover, the aging population is particularly susceptible to GI-related health issues, driving demand for effective diagnostic tools and interventions. The versatility of GI endoscopy in both diagnostic and therapeutic applications enhances its attractiveness in clinical settings, making it the favored choice among healthcare professionals.
   
• The second-largest segment, the pulmonary segment, held a market share of 25.3% in 2024, driven by the rising prevalence of chronic respiratory conditions such as COPD and lung cancer.
   
• The ENT endoscopy segment, though smaller with a market share of 15.2%, is expected to grow at a CAGR of 7.6%, supported by the growing demand for outpatient procedures for sinusitis, vocal cord disorders, and nasal polyps. The segment benefits from the compact design and high-definition visualization capabilities of modern flexible endoscopes, which enhance precision in delicate anatomical areas.
   
• The urology segment accounted for 10.9% of the market in 2024, primarily due to the widespread use of ureteroscopes and cystoscopes in the management of kidney stones, bladder cancer, and other urological conditions.
   
• Other applications, including gastrointestinal, gynecological, and pediatric procedures, collectively contributed to a growing share of 8% in the market in 2024. These areas are witnessing increased adoption due to the versatility and patient comfort offered by flexible endoscopes.
   

Based on the end use, the flexible endoscopes market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment accounted for the highest market share of 59.9% in 2024, owing to the combination of advanced technology, skilled personnel, and shifting patient preferences toward outpatient care.
 

• The dominant market share is attributed to the increasing adoption of advanced flexible endoscopes in hospitals, which offer improved maneuverability and are expected to drive greater patient preference for hospital-based procedures.
   
• The growth of the hospitals and clinics segment is further driven by rising admissions for lifestyle-related disorders, expanded disease screening programs, and the presence of highly qualified medical professionals.
   
• Moreover, the presence of multidisciplinary teams comprising gastroenterologists, pathologists, and surgical staff enhances the capability of hospitals and clinics to provide high-quality care, which further attracts patients.
   
• The ambulatory surgical centers segment, pulmonary segment, held a market share of 28.9% in 2024, driven by the rising demand for cost-effective, same-day procedures.
   
• Other applications, including diagnostic laboratories, academic institutions, and long-term care facilities, collectively contributed to a growing share of 11.3% in the market in 2024. Growth in this segment is supported by the use of flexible endoscopes in research, training, and niche clinical applications.
   

North America dominated the global flexible endoscopes market with the highest market share of 41.1% in 2024.
 

• The U.S. market was valued at USD 2.7 billion and USD 2.8 billion in 2021 and 2022, respectively. In 2024, the market size grew to USD 3.2 billion from USD 3 billion in 2023.
   

• North America’s dominance in the market is driven by a combination of advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and an aging population that requires frequent diagnostic and therapeutic procedures in the U.S. and Canada.  
   
• The U.S., as the largest market within this region, contributes significantly to the overall growth. The presence of numerous healthcare facilities equipped with state-of-the-art endoscopy equipment, combined with a growing geriatric population that requires frequent screenings, continues to propel the demand for flexible endoscopes.
   
• Furthermore, robust healthcare spending and a focus on preventive care are fueling growth in various endoscopic procedures, making the U.S. a pivotal player in the flexible endoscope market.
   

Europe flexible endoscopes market accounted for USD 2.2 billion in 2024.
 

• Europe's favorable regulatory framework, particularly under the EU Medical Device Regulation (MDR), has reinforced safety and efficacy standards, building confidence among healthcare providers and patients.
   
• Germany stands out as one of the largest markets in Europe, driven by its reputation for high-quality healthcare services and medical innovation.
   
• The country has a significant number of hospitals and outpatient clinics that utilize flexible endoscopes for diverse applications, including gastrointestinal diagnostics and surgeries.
   
• Additionally, partnerships between healthcare providers and endoscope manufacturers contribute to Germany’s substantial market share in the region.
   

The Asia Pacific flexible endoscopes market is anticipated to grow at the highest CAGR of 8.7% during the analysis timeframe.
 

• The Asia Pacific region is witnessing rapid growth in the market due to improving healthcare infrastructure and rising investment in medical technologies.
   
• China is a key player in this region, where the demand for flexible endoscopes is amplified by an expanding population and a high prevalence of gastrointestinal diseases.
   
• The country is at the forefront of innovation in endoscopic technology, with many leading manufacturers headquartered in the country. High rates of gastric cancer screening and a proactive approach to early disease detection have propelled the adoption of flexible endoscopes.
   
• China’s strong focus on minimally invasive procedures and the integration of AI-powered diagnostic tools into endoscopy further solidifies its significant market share in the Asia-Pacific region.
   

Latin America flexible endoscopes market is anticipated to record robust growth throughout the forecast period.
 

• Countries like Brazil in Latin America are at the forefront of this growth, driven by both public and private investments in healthcare services. The Brazilian government is implementing policies to improve healthcare access, which include the expansion of diagnostic services such as endoscopy.
   
• Additionally, the rising prevalence of gastrointestinal disorders within the population, coupled with the availability of affordable healthcare solutions, is further stimulating the demand for flexible endoscopes in the region.
   

Middle East and Africa flexible endoscopes market is anticipated to record significant growth throughout the forecast period.
 

• Many countries in the region, including South Africa, are working to enhance their healthcare systems, leading to an increase in the adoption of advanced medical equipment, including flexible endoscopes.
   
• Growing awareness of health issues and a rise in lifestyle-related diseases have prompted healthcare providers to focus more on diagnostic and therapeutic capabilities.
   

Flexible Endoscopes Market Share

Leading companies like Boston Scientific, Olympus, and Fujifilm together hold between 60 - 70% of the market share in the fragmented global market. These businesses keep their dominance by combining strong product lines, business alliances, legal clearances, and ongoing innovation. Boston Scientific holds a strong competitive advantage with its LithoVue Single-Use Digital Flexible Ureteroscope, widely adopted in hospitals and clinics to perform endoscopic procedures.
 

Olympus Corporation has introduced cutting-edge endoscopic technologies, such as the ENDOEYE and EVIS systems, emphasizing high-definition imaging and ease of navigation. By leveraging partnerships with healthcare institutions, Olympus aims to enhance training programs and improve the overall quality of endoscopic procedures. Their commitment to integrating AI-based technologies into endoscopy is further pushing the boundaries of what is achievable in diagnostics and surgical interventions.
 

Fujifilm, a major competitor in the market, has adopted competitive pricing strategies for its range of flexible endoscopes, aiming to capture a larger share of the market by making advanced imaging techniques more accessible to smaller healthcare facilities.
 

Other players Medtronic, have focused on the development of flexible endoscopes that can accommodate advanced therapeutic applications, such as lesion treatment and biopsies, thereby offering a dual function in both diagnosis and treatment. Their innovative technologies are designed to cater to the specific needs of various specialties, including gastroenterology and pulmonology, facilitating a broader range of applications in patient care.
 

Flexible Endoscopes Market Companies

Few of the prominent players operating in the flexible endoscopes industry include:

• BD
• Boston Scientific
• CooperSurgical
• ENDOMED SYSTEMS
• FUJIFILM
• Laborie
• Machida
• OLYMPUS
• PENTAX Medical
• RICHARD WOLF
• STORZ
• XION

 

Boston Scientific

Boston Scientific excels in integrating cutting-edge imaging and therapeutic capabilities, ensuring that its products not only provide high-quality images but also facilitate precise interventions. This functionality is pivotal in improving patient outcomes, making Boston Scientific a trusted partner in minimally invasive therapies across various medical fields.
 

Becton Dickinson (BD)

BD’s strength in the flexible endoscopes market lies in its precision engineering and infection control technologies. While not a dominant player in visualization systems, BD contributes through accessories and sterilization solutions that enhance the safety and longevity of endoscopic procedures. Its focus on clinical reliability and device integration supports hospitals in maintaining high procedural standards.
 

Olympus

Olympus’s focus on integrating AI and digital solutions enhances procedural efficiency and training, setting them apart in the competitive landscape. Their dedication to improving surgical outcomes and patient comfort solidifies Olympus’s reputation as a leading force in the flexible endoscope market.
 

Medtronic

Medtronic's USP revolves around its comprehensive approach to innovative medical technology and a strong commitment to improving patient health. With a focus on flexible endoscopes designed for therapeutic applications, Medtronic provides solutions that combine diagnostic capabilities with treatment functionalities, such as in their offerings for gastrointestinal and pulmonary needs.
 

Flexible Endoscopes Industry News:

• In May 2021, PENTAX Medical and Vedkang Medical Science and Technology announced a Joint venture to develop single-use flexible endoscope devices. This joint venture helped the company to strengthen the commercialization of the product and expand the product portfolio of the company.
   
• In August 2021, Boston Scientific received approval for its EXALT Model B Single-Use Bronchoscope. This bronchoscope is developed as a substitute for reusable bronchoscopes. This strategic move helped the company expand its product portfolio across multiple care segments.
   

The flexible endoscopes market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in units from 2021 - 2034 for the following segments:

Market, By Product

• Videoendoscope
• Fiberscope

Market, By Application

• GI endoscopy
• Pulmonary endoscopy
• ENT endoscopy
• Urology
• Other applications

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE